Richard Edmondson

Biography

Richard qualified in medicine from Newcastle University in 1992 and after a year of surgical training in New Zealand undertook speciality training in the Northern Deanery in Obstetrics and Gynaecology with subspecialty training in Gynaecological Oncology at the Queen Elizabeth Hospital, Gateshead. He was awarded an MD from Newcastle University in 2002 for his work investigating the biology of the ovarian surface epithelium which led to his current interest in ovarian cancer biology.

He was appointed as a consultant in Gateshead and honorary senior lecturer in Newcastle in 2005 and since then, in addition to developing techniques in extended surgery for ovarian cancer, he has developed a translational research group investigating potential therapeutic biomarkers. His group has developed techniques to establish real time models for ex vivo testing of drug sensitivity alongside functional assessment of the tumour and this has led to exciting developments in the ability to predict response to novel agents including PARP inhibitors as well as conventional chemotherapy agents such as carboplatin.

In addition he chairs the endometrial subgroup of the NCR clinical studies group and works to increase the number and breadth of portfolio studies in endometrial cancer.

In January 2014 he took up the chair of Gynaecological Oncology at the University of Manchester.

Biology, Medicine and Health (BMH) Domains

• Cancer